BG106210A - Means of chemotherapy and chemoprophylaxis of flavivirus infections - Google Patents

Means of chemotherapy and chemoprophylaxis of flavivirus infections

Info

Publication number
BG106210A
BG106210A BG106210A BG10621001A BG106210A BG 106210 A BG106210 A BG 106210A BG 106210 A BG106210 A BG 106210A BG 10621001 A BG10621001 A BG 10621001A BG 106210 A BG106210 A BG 106210A
Authority
BG
Bulgaria
Prior art keywords
virus
encephalitis
diseases
species
chemoprophylaxis
Prior art date
Application number
BG106210A
Other languages
Bulgarian (bg)
Other versions
BG65190B1 (en
Inventor
Ангел ГЪЛЪБОВ
Original Assignee
Ангел ГЪЛЪБОВ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ангел ГЪЛЪБОВ filed Critical Ангел ГЪЛЪБОВ
Priority to BG106210A priority Critical patent/BG65190B1/en
Publication of BG106210A publication Critical patent/BG106210A/en
Publication of BG65190B1 publication Critical patent/BG65190B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to the application of compound 1-(4-morpholinomethyl)-tetrahydro-2-[1H]-pyrimidinon with the formula for making preparations of chemotherapeutic and chemoprophylactic effect against infections caused by flaviviruses of the Flavivirus species, such as the virus of the tick encephalitis, of the diseases of the Kiasanurski forest, of the Omsk haemorrhagic fever, the Langat virus, the Western Nile virus, the Japanese encephalitis, the encephalitis of the Valley of Murray, the St Luis encephalitis, the Denga virus of the mucous diseases - viral bovine diarrhoea, the border sheep disease, and of the species of the hepatitis C virus. 4 claims
BG106210A 2001-12-12 2001-12-12 Flavivirus infections chemotherapy and chemoprophylaxis means BG65190B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BG106210A BG65190B1 (en) 2001-12-12 2001-12-12 Flavivirus infections chemotherapy and chemoprophylaxis means

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BG106210A BG65190B1 (en) 2001-12-12 2001-12-12 Flavivirus infections chemotherapy and chemoprophylaxis means

Publications (2)

Publication Number Publication Date
BG106210A true BG106210A (en) 2003-06-30
BG65190B1 BG65190B1 (en) 2007-06-29

Family

ID=3928594

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106210A BG65190B1 (en) 2001-12-12 2001-12-12 Flavivirus infections chemotherapy and chemoprophylaxis means

Country Status (1)

Country Link
BG (1) BG65190B1 (en)

Also Published As

Publication number Publication date
BG65190B1 (en) 2007-06-29

Similar Documents

Publication Publication Date Title
WO2002048165A3 (en) Antiviral agents for treatment of flaviviridae infections
WO2003005999A3 (en) Methods of treating cytokine mediated diseases
ATE508735T1 (en) PULMONARY ADMINISTRATION OF AMINOGLYCOSIDES
PT1268519E (en) PROTEASE SERINE INHIBITORS, PARTICULARLY PROTEASE NS3 HEPATITIS C VIRUS
EP2431379A3 (en) HCV inhibitors
BRPI0113286B8 (en) substituted pyrazoles and pharmaceutical composition comprising the same.
WO2002008198A3 (en) Novel imidazolidinones as ns3-serine protease inhibitors of hepatitis c virus
WO2002008244A3 (en) Peptides as ns3-serine protease inhibitors of hepatitis c virus
WO2001062737A3 (en) Amino pyrazole derivatives useful for the treatment of obesity and other disorders
ATE296826T1 (en) PYRAZOLO(1,5)PYRIDINE DERIVATIVES
HK1046004A1 (en) Recombinant gelatins
NO20042298L (en) Pharmaceutical preparations and their uses
WO2003000200A3 (en) β-2'-OR 3'-HALONUCLEOSIDES
BR0305259A (en) Hcv ns5b polymerase inhibitors
MXPA03006224A (en) Inhibitors of cruzipain and other cysteine proteases.
ATE349448T1 (en) PYRAZOLE-3,4-D-PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF H.PYLORI INFECTIONS
MXPA03010158A (en) Sulfonamides.
HUP0303813A3 (en) Arylsulfonamides as antiviral agents, process for preparation of the compounds and pharmaceutical compositions containing them
IL159993A0 (en) Platinum complexes and their use in cancer treatment
WO2002085358A3 (en) Antiviral agents and methods of treating viral infections
MXPA03011128A (en) Flavour and fragrance compositions.
WO2004099165A3 (en) Heterocyclic compounds and hydro isomers thereof
BG106210A (en) Means of chemotherapy and chemoprophylaxis of flavivirus infections
WO2002000613A3 (en) Inhibitors of hepatitis b virus infection
HUP0500164A3 (en) Heterocyclic substituted benzenesulfonamides as hiv protease inhibitors and pharmaceutical compositions containing them